Wannan rahoto mai shafi 150 yana ba da bayyani na kasuwar sa ido kan masu haƙuri ta duniya (RPM).Binciken da ke cikin wannan rahoton ya dogara ne akan kasuwar sa ido kan haƙuri (RPM).Yana da cikakken bayyani na kasuwa, wanda ya shafi dukkan bangarorin tsarin kasuwa na yanzu.Ya tara cikakkun bayanai da hanyoyin bincike.Rahoton bincike na kasuwar Nesa Kulawa da Haƙuri (RPM) cikakken bincike ne na yanayin kasuwa na yanzu, wanda ke rufe haɓakar kasuwanni da yawa.
A cikin 2019, kasuwar sa ido kan masu haƙuri ta duniya (RPM) ta kai dalar Amurka biliyan 16.54 kuma ana tsammanin za ta kai dalar Amurka biliyan 195.91 nan da shekarar 2027, tana ƙaruwa a ƙimar haɓakar shekara-shekara na 36.2% a lokacin hasashen.
Dangane da nazarin rahoton kasuwa, saka idanu mai nisa (RPM) fasaha ce da ake amfani da ita don tattara bayanan likita da kiwon lafiya daga mutane a wuri ɗaya da watsa ta hanyar lantarki zuwa masu ba da lafiya a wani wuri.Ana amfani da RPM don saka idanu mai nisa da kuma nazarin sigogi na ilimin lissafi, kamar matakin oxygen na jini, alamun mahimmanci, hawan jini, bugun zuciya, da sukarin jini, don haka inganta ingancin kulawa da ingancin rayuwa, da tsinkayar lalacewa da lalacewa da wuri.Wannan yana rage yawan ziyartar dakin gaggawa da kuma tsawon zaman asibiti.
Wasu mahimman mahimman abubuwan da ke haifar da haɓakar kasuwar sa ido kan haƙuri ta duniya (RPM) sune ci gaba a cikin sadarwa da haɓaka saka hannun jari a cikin telemedicine da sa ido kan haƙuri.Koyaya, amfani da ayyukan kafofin watsa labarun na yau da kullun yana hana ci gaban kasuwa.
Wannan cikakken rahoton bincike na kasuwa na saka idanu na haƙuri (RPM) daga 2019 zuwa 2027 yana gabatar da waɗannan abubuwan a taƙaice kuma yana iya taimakawa kamfanoni a cikin wannan masana'antar fahimtar kasuwa da tsara dabarun faɗaɗa kasuwanci daidai.Rahoton binciken yayi nazarin girman kasuwa, rabon masana'antu, haɓaka, manyan sassan kasuwa, adadin haɓakar shekara-shekara da mahimman abubuwan tuƙi.
Bincike mai zurfi game da tasirin COVID-19 akan kasuwar sa ido na nesa (RPM) a cikin 2021 |Za mu keɓance rahoton bisa ga buƙatunku-samu yanzu!!
Nemi rangwame akan daidaitaccen farashin wannan babban rahoton @ https://marketprognosis.com/discount-request/20399.
GE Healthcare (Mayu 10, 2021) - GE Healthcare ya ƙaddamar da wani sabon tsari mai mahimmanci tare da AI-kunna makaman nukiliya daidai aikace-aikacen kiwon lafiya-don taimakawa likitocin likitancin nukiliya su samar da sassauci mafi girma kuma Don ƙarin lokacin haƙuri, GE Healthcare a yau ta ƙaddamar da Xeleris Va sabon sarrafa kayan aiki. da sake dubawa bayani.Xeleris V yana kawar da buƙatar wurin aikin likitancin nukiliya mai zaman kansa, don haka likitocin za su iya samun damar bayanai daga wurare daban-daban cikin aminci.Wannan karuwa a cikin ziyarar, haɗe tare da sababbin aikace-aikacen da aka kunna AI da GE Healthcare's babbar cibiyar shigar da kyamarar maganin nukiliya, na iya sauƙaƙe da haɓaka ayyukan aiki, taimakawa likitocin da sauri da kuma ganewa daidai, ganowa, da kuma kula da marasa lafiya.
"Yayin da muke aiki don sake ginawa, maidowa, da kuma sake tunani game da kiwon lafiya na gaba, mun yi imanin cewa basirar wucin gadi za ta taka muhimmiyar rawa wajen taimakawa tsarin kiwon lafiya ya kara yawan amfani da albarkatun don samar da kulawa ta musamman cikin sauri da sauƙi," kwayoyin Jean- Luc Procaccini, Shugaba da Shugaba na Hoto da Kwamfuta, ya bayyana zane-zane, GE Healthcare."Xeleris V yana taimakawa wajen yin wannan ta hanyar samar wa likitocin sabuwar hanyar aiki, ba su damar samun ƙarin lokaci don raka majiyyatan su, da kuma taimaka musu su yi amfani da sabuwar fasahar zamani a kan dukkan na'urori don saurin ganewar asali."
Binciken kasuwa ya nuna cewa kashi 73% na masu aikin rediyo suna tsammanin ingancin aiki zai zama babban kalubale a cikin shekaru 1-3 masu zuwa, yayin da kashi 64% na likitocin da aka bincika sun nuna cewa ƙoshin likitoci ya karu yayin bala'in.Waɗannan ƙididdiga sun nuna haɓaka buƙatun yau don haɓaka sassauƙa, samun dama, da inganci na kiwon lafiya.
"Ba wanda yake so ya danna windows akan wurin aiki duk rana, amma ayyukan aiki na yau (kamar sassan sassan jiki) suna cin lokaci, gajiyawa, da dogaro sosai ga ma'aikata," in ji Avi, Farfesa na Magunguna, MD, da Ph. D.Daraktan Sashen Magungunan Nukiliya na Asibitin Mori."Kwantar da waɗannan ayyukan aiki da sauƙin samun maimaitawa da ingantaccen sakamako yana da mahimmanci ga samar da ƙimar ƙimar haƙuri da magani."
Xeleris V yana kawar da iyakokin wuraren aikin likitancin nukiliya na al'ada, kuma yana ba wa likitocin da keɓaɓɓen bayani mai sauƙi da sassaucin ra'ayi wanda ke ba likitoci damar samun damar bayanai daga ko'ina - yana taimaka musu yin yanke shawara na Nursing da shawarwarin jiyya sune ainihin ainihin madaidaicin. lafiya.
"Tare da fasahar fasaha ta wucin gadi, mun sami saurin sauri, amincewa, da maimaitawa - yana canza tsarin aikin rediyo ta hanyar samar da sakamako daidai, yana taimakawa wajen fadada amfani da magungunan nukiliya don keɓance hanyoyin kula da marasa lafiya," Farfesa Susang ya kara da cewa maganin nukiliyar sa. Teamungiyar Asibitin Avicen sun kimanta sabon maganin Q. Lung AI na GE Healthcare."Ko da a cikin aikina, na lura cewa yayin da muke samun amincewar ƙungiyar tiyata ta hanyar samar da sakamako daidai, muna da damar da za mu ƙara shiga cikin jagorancin kulawar da aka ba wa kowane majiyyaci."
PharmiWeb.com ita ce babbar hanyar haɗin gwiwar masana'antar harhada magunguna ta Turai, tana ba da sabbin ayyuka, labarai, fasali da jerin abubuwan da suka faru.Bayanin da aka bayar akan PharmiWeb.com an yi niyya don tallafawa maimakon maye gurbin dangantakar haƙuri/majiyyaci.Baƙon wurin da likitansa.
Disclaimer: Yanzu kuna barin gidan yanar gizon PharmiWeb.com kuma kuna zuwa gidan yanar gizon da ba mu sarrafa shi ba.Ba mu da alhakin abun ciki ko samuwar shafukan da aka haɗa.
PharmiWeb.com yana ba da hanyoyin haɗi zuwa wasu gidajen yanar gizo na ɓangare na uku waɗanda ƙila su kasance masu sha'awar baƙi zuwa gidan yanar gizon mu.Hanyoyin haɗin yanar gizon da aka bayar a cikin gidan yanar gizon mu kawai don dacewa da ku kuma zasu iya taimaka muku samun wasu bayanai masu amfani akan Intanet.Lokacin da kuka danna waɗannan hanyoyin, zaku bar gidan yanar gizon PharmiWeb.com kuma a tura ku zuwa wani rukunin yanar gizon.Waɗannan rukunin yanar gizon ba sa ƙarƙashin ikon PharmiWeb.com.
PharmiWeb.com bashi da alhakin abun ciki na rukunin yanar gizo na ɓangare na uku da aka haɗa.Mu ba wakili ne na waɗannan ɓangarori na uku ba, kuma ba mu yarda ko garantin samfuran su ba.Ba mu yin wakilci ko garanti game da daidaiton bayanan da ke ƙunshe a cikin rukunin yanar gizon da aka haɗa.Muna ba da shawarar cewa koyaushe ku tabbatar da bayanan da aka samu daga gidan yanar gizon da aka haɗa kafin ɗaukar mataki bisa wannan bayanin.
Bugu da kari, da fatan za a lura cewa manufofin tsaro da keɓantawa akan waɗannan rukunin yanar gizon na iya bambanta da na PharmiWeb.com, don haka da fatan za a karanta tsare-tsaren sirri da tsare-tsare na ɓangare na uku a hankali.
Idan kuna da wasu tambayoyi ko damuwa game da samfuran da sabis ɗin da aka bayar akan gidan yanar gizon ɓangare na uku da aka haɗa, da fatan za a tuntuɓi ɓangare na uku kai tsaye.
Lokacin aikawa: Juni-17-2021